General & internal medicine Public health, health care sciences & services Endocrinology, metabolism & nutrition
Author, co-author :
Reginster, Jean-Yves ; Université de Liège - ULiège > Département des sciences de la santé publique > Santé publique, Epidémiologie et Economie de la santé
Bruyère, Olivier ; Université de Liège - ULiège > Département des sciences de la santé publique > Santé publique, Epidémiologie et Economie de la santé
Albright F. (1941) Postmenopausal osteoporosis. JAMA 116:2465.
Rosen C.J., Kessenich C.R. (1997) The pathophysiology and treatment of postmenopausal osteoporosis. An evidence-based approach to estrogen replacement therapy. Endocrin Metab Clin North Am 26:295-311.
Eastell R. (1998) Treatment of postmenopausal osteoporosis. N Engl J Med 338:736-746.
Lindsay R. (1987) Estrogen therapy in the prevention and management of osteoporosis. Am J Obstet Gynecol 156:1347-1351.
Ott S. (1992) Estrogen therapy for osteoporosis - Even in the elderly. Ann Int Med 117:85-86.
Tosteson A., Rosenthal D.I., Melton L.J., Weinstein M.C. (1990) Cost effectiveness of screening perimenopausal white women for osteoporosis: Bone densitometry and hormone replacement therapy. Ann Intern Med 113:594-603.
Genant H.K., Lucas J., Weiss S. (1997) Low-dose esterifled estrogen therapy. Arch Intern Med 157:2609-2615.
Cauley J.A., Seeley D.G., Ensrud K. (1995) Estrogen replacement therapy and fractures in older women. Ann Intern Med 122:9-16.
1994.
.
Bland C.J., Meurer L.N., Maldonado G. (1995) A systematic approach to conducting a non-statistical meta-analysis of research literature. Acad Med 70:642-653.
Nachtigall L., Nachtigall R., Beckman E. (1979) Estrogen replacement therapy I: A 10-year prospective study in the relationship to osteoporosis. Obstet Gynecol 53:277-281.
Genant H., Lucas J., Weiss S. Low-dose esterified estrogen therapy. Arch Intern Med 157:2609-2615.
Riis B., Thomsen K., Strom V. (1987) The effect of percutaneous estradiol and natural progesterone on postmenopausal bone loss. Am J Obstet Gynecol 156:61-66.
Devogelaer J.P., Lecart C., Dupret P. Long-term effects of percutaneous estradiol on bone loss and bone metabolism in postmenopausal hysterectomized women. Maturitas 28:243-249.
Lufkin E., Wahner H., O'Fallon W. (1992) Treatment of postmenopausal osteoporosis with transdermal estrogen. Ann Int Med 117:1-9.
Holland E., Leather A., Studd J. (1995) Increase in bone mass of older postmenopausal women with low mineral bone density after one year of percutaneous oestradiol implants. Br J Obstet Gynecol 102:238-242.
Holland E., Leather A., Studd J. (1994) The effect of 25-mg percutaneous estradiol implants on the bone mass of post-menopausal women. Obstet Gynecol 83:43-46.
Quigley M., Martin P., Bumier A. Estrogen therapy arrests bone loss in elderly women. Am J Obstet Gynecol 156:1516-1523.
(1996) Effects of hormone therapy on bone mineral density. JAMA 276:1389-1396.
Christiansen C., Riis B. (1990) 17β-Estradiol and continuous norethisterone: A unique treatment for established osteoporosis in elderly women. J Clin Endocrinol Metab 71:836-841.
Lindsay R. (1980) Prevention of spinal osteoporosis in oophorectomised women. Lancet 1:1152-1154.
Ettinger B., Genant H., Cann C. (1985) Long-term estrogen replacement therapy prevents bone loss and fractures. Ann Int Med 102:319-324.
Maxim P., Ettinger B., Spitalny M. (1995) Fracture protection provided by long-term estrogen treatment. Osteoporosis Int 5:23-29.
Grady D., Rubin S., Petitti D. (1992) Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Int Med 17:1016-1037.
Hulley S., Grady D., Bush T. (1998) Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. JAMA 280:605-613.
Komulainen M., Kroger H., Tupurainen M. (1998) HRT and Vit D in prevention of nonvertebral fractures in postmenopausal women: A 5-year randomized trial. Maturitas 31:45-54.
Nguyen T., Jones G., Sambrook N. (1995) Effects of estrogen exposure and reproductive factors on bone mineral density and osteoporotic fractures. J Clin Endocrinol Metab 80:2709-2714.
Kiel D., Baron J., Anderson J. (1992) Smoking eliminates the protective effect of oral estrogens on the risk for hip fracture among women. Ann Int Med 116:716-721.
Kanis J., Johnell O., Guliberg B. (1992) Evidence for efficacy of drugs affecting bone metabolism in preventing hip fracture. Br Med J 305:1124-1128.
Michaelson K., Baron J., Farahmand B. (1998) Hormone replacement therapy and risk of hip fracture: Population-based case-control study. Br Med J 316:1858-1863.
Michaelson K., Baron J., Johnell O. (1998) Variation in the efficacy of hormone replacement therapy in the prevention of hip fracture. Osteoporosis Int 8:540-546.
Cauley J., Cummings S., Black D. (1990) Prevalence and determinants of estrogen replacement therapy in elderly women. Am J Obstet Gynecol 163:1438-1444.
Ettinger B., Li D., Lein R. (1996) Continuation of postmenopausal hormone replacement therapy: Comparison of cyclic versus continuous combined schedules. Menopause 3:185-189.
Groeneveld F., Bareman F., Barentsen R. (1998) Duration of hormonal replacement therapy in general practice: A follow-up study. Maturitas 29:125-131.
Ryan P., Harrison R., Blake G. (1992) Compliance with hormone replacement therapy (HRT) after screening for post-menopausal osteoporosis. Br J Obstet Gynecol 99:325-328.
Lindsay R., Bush T.L., Grady D. (1996) Therapeutic controversy - Estrogen replacement in menopause. J Clin Endocrinol Metab 81:3829-3838.
